Shocking info: Dangers of deterenol revealed
Shocking it may sound, but researchers have urged consumers to avoid using weight loss or sports supplements that list deterenol as an ingredient.
Scientists at...
Johnson & Johnson single-dose Covid-19 vaccine gets emergency use listing by WHO
Johnson & Johnson has announced that the World Health Organization (WHO) has issued Emergency Use Listing (EUL) for its single-shot COVID-19 vaccine.
It has been...
HKBU develops new Chinese medicine formula for Alzheimer’s disease
Hong Kong Baptist University's (HKBU) School of Chinese Medicine researchers have developed a Chinese medicine formula named NeuroDefend.
The new formula offers a potential novel...
Matrix Medical Network ties up with AstraZeneca
Matrix Medical Network has announced a partnership with AstraZeneca to accelerate a clinical trial in the US for AZD7442, AstraZeneca's long-acting monoclonal antibody (LAAB)...
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19 vaccine candidate
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
RedHill Biopharma expands manufacturing capacity of Opaganib for COVID-19 with Cosmo Pharma
RedHill Biopharma Ltd has announced a manufacturing agreement with Cosmo Pharmaceuticals NV.
According to the specialty biopharmaceutical company, the partnership is to further expand manufacturing...
Women’s reproductive healthcare gets boost with home blood-testing kit for fertility
Women's fertility issues received a boost, as health start-up Yesmom announced the launch of Asia's first at-home blood testing kits for female fertility, designed...
Biohaven gives important update on phase 2/3 trial and Alzheimer’s disease program
Biohaven Pharmaceutical Holding Company Ltd has announced completed a focused analysis of the topline co-primary and key secondary data from its Phase 2/3 clinical...
NIH & BARDA react to emergency use authorisation of Moderna Covid-19 vaccine by FDA
NIH and BARDA have reacted to the United States Food and Drug Administration's Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based...
Research on preventative nasal spray reveals interesting results
Research on a 'novel' nasal spray therapy, INNA-051, which has been shown to reduce Covid-19 viral replication by up to 96 percent in a...
